Tandem Diabetes Care Inc.
Organization details
- Legal name
- Tandem Diabetes Care Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- San Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TNDM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001438133
- EIN
- 20-4327508
- Wikidata ID
- Q22121872
Board of directors
-
Christopher J. Twomey · DirectorSince 2023
-
Dick Allen · DirectorSince 2023
-
Joao Paulo Falcao Malagueira · DirectorSince 2023
-
John F. Sheridan · Director · PRESIDENT & CEOSince 2023
-
Kathleen McGroddy-Goetz · DirectorSince 2023
-
Kim D. Blickenstaff · DirectorSince 2023
-
Myoungil Cha · DirectorSince 2023
-
Peyton R. Howell · DirectorSince 2023
-
Rajwant Sodhi · DirectorSince 2023
-
Rebecca B. Robertson · DirectorSince 2023
-
Sandra Beaver · DirectorSince 2025
Chief executives
Director election results
Annual meeting of May 20, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
87.2%
-
98.6%
-
98.6%
-
98.8%
-
98.9%
-
99.0%
-
99.1%
-
99.1%
-
99.4%
Board connections
3 of this board's directors also sit on 3 other boards. 2 are in the same sector.
- via Christopher J. Twomey
-
CeriBell Inc. Same sectorvia Rebecca B. Robertson
-
Nuvation Bio Inc. Same sectorvia Kim D. Blickenstaff
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $36,911
- 3 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 27, 2026 | Christopher J. Twomey Director | Option exercise | +1,700 | $19.00 | $32,300 |
| Oct 27, 2026 | Christopher J. Twomey Director | Open-market sale | −1,700 | $19.15 | $32,555 |
| Oct 15, 2026 | Kyrillos Jean-Claude Officer (EVP & Chief Operating Officer) | Option exercise | +3,637 | — | — |
| Oct 15, 2026 | Kyrillos Jean-Claude Officer (EVP & Chief Operating Officer) | Shares withheld for tax | −1,926 | $16.52 | $31,818 |
| Aug 15, 2026 | Carpenter Rick Officer (EVP & Chief Technology Officer) | Option exercise | +897 | — | — |
| Aug 15, 2026 | Gasser Elizabeth Anne Officer (EVP, Chief Strategy Officer) | Option exercise | +1,097 | — | — |
| Aug 15, 2026 | Hansen Shannon Marie Officer (EVP & Chief Legal Officer) | Option exercise | +1,097 | — | — |
| Aug 15, 2026 | Kyrillos Jean-Claude Officer (EVP & Chief Operating Officer) | Option exercise | +1,010 | — | — |
| Aug 15, 2026 | Morrison Susan Officer (EVP & Chief Admin. Officer) | Option exercise | +1,097 | — | — |
| Aug 15, 2026 | John F. Sheridan Director, Officer (PRESIDENT & CEO) | Option exercise | +5,982 | — | — |
| Aug 15, 2026 | Vosseller Leigh Officer (EVP & CHIEF FINANCIAL OFFICER) | Option exercise | +1,496 | — | — |
| Aug 15, 2026 | Carpenter Rick Officer (EVP & Chief Technology Officer) | Shares withheld for tax | −457 | $22.72 | $10,383 |
| Aug 15, 2026 | Gasser Elizabeth Anne Officer (EVP, Chief Strategy Officer) | Shares withheld for tax | −589 | $22.72 | $13,382 |
| Aug 15, 2026 | Hansen Shannon Marie Officer (EVP & Chief Legal Officer) | Shares withheld for tax | −559 | $22.72 | $12,700 |
| Aug 15, 2026 | Kyrillos Jean-Claude Officer (EVP & Chief Operating Officer) | Shares withheld for tax | −535 | $22.72 | $12,155 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Tandem Diabetes Care Inc.
Who is the CEO of Tandem Diabetes Care Inc.?
John F. Sheridan is Tandem Diabetes Care Inc.'s PRESIDENT & CEO.
How many directors are on Tandem Diabetes Care Inc.'s board?
Tandem Diabetes Care Inc.'s board has 11 directors: Christopher J. Twomey, Dick Allen, Joao Paulo Falcao Malagueira, John F. Sheridan, Kathleen McGroddy-Goetz, Kim D. Blickenstaff, Myoungil Cha, Peyton R. Howell, Rajwant Sodhi, Rebecca B. Robertson and 1 other.
Are Tandem Diabetes Care Inc. insiders buying or selling shares?
Over the last 12 months, Tandem Diabetes Care Inc. insiders made no open-market purchases and sold $36,911 of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="tandem-diabetes-care-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.